10 employees
Amylon Therapeutics is a biotechnology company that uses RNA Modulation Technology to target rare genetic disorders.
2017
$349K
from 1 investors over 1 rounds
Amylon Therapeutics raised $349K on November 9, 2017
Investors: UNIIQ - Finance for the Future